Appendix 4C and Quarterly Activities Report
Filed with ASX · · 14 pages · English
• Operational Performance: Daily clinical billing productivity continued to improve materially. Compared to the September 2025 quarter baseline, average billing per day increased by 22% in the December quarter, and the January 2026 run-rate is now 50+% above September 2025 levels, which the Board believes reflects improved platform capability, workflow optimisation, deeper patient engagement and g
Vitasora Health Limited on 6ix
Story so far
Earlier from Vitasora Health
- Completion of A$11m Raise and Cornerstone Investment
- Quarterly Activities/Appendix 4C Cash Flow Report
- Vitasora Expands U.S. Partnership with Evolent
- Vitasora Cornerstone Investor Placement Update
- June 2025 Appendix 4E
Later from Vitasora Health
- Appendix 4D and Half Year Financial Report
- Vitasora Execute vCare Rollout - Revenue Scaling Accelerates
- VHL Raises $4m Cornerstoned by $3m Strategic Investment
- June 2026 Appendix 4E
- Vitasora Market Update Presentation - October 2026
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health